Altered expression of the receptor and ligand in the TGFβ signaling pathway in diffusely infiltrating colon carcinoma

Anticancer Research

Volumn 22, Issue 6 B, 2002, Pages 3545-3554

  Nagayama, Satoshi ^a,b   Onodera, Hisashi ^a   Toguchida, Junya ^b   Imamura, Masayuki ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Immunohistochemistry; Methylation; Mutation; Promoter activity

Indexed keywords

AMINO ACID; CYTOSINE; GUANINE; LIGAND; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2 RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER INVASION; CLINICAL ARTICLE; COLORECTAL CARCINOMA; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MISSENSE MUTATION; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; SOMATIC MUTATION;

COLONIC NEOPLASMS; DNA METHYLATION; FEMALE; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LUCIFERASES; MALE; MUTATION, MISSENSE; PROLIFERATING CELL NUCLEAR ANTIGEN; PROMOTER REGIONS (GENETICS); RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 0036875138     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Nakahara H, Ishikawa T, Itabashi M and Hirota T: Diffusely infiltrating primary colorectal carcinoma of linitis plastica and lymphangiosis types. Cancer 69: 901-906, 1992.
2. Shirouzu K, Isomoto H, Morodomi T, Ogata Y, Akagi Y and Kakegawa T: Primary linitis plastica carcinoma of the colon and rectum. Cancer 74: 1863-1868, 1994.
3. Papp JP Jr, Levine EJ and Thomas FB: Primary linitis plastica carcinoma of the colon and rectum. Am J Gastroenterol 90: 141-145, 1995.
4. Messerini L, Palomba A and Zampi G: Primary signet-ring cell carcinoma of the colon and rectum. Dis Colon Rectum 38: 1189-1192, 1995.
5. Derynck R, Akhurst RJ and Balmain A: TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 29: 117-129, 2001.
6. Gomella LG, Sargent ER, Wade TP, Anglard P, Linehan WM and Kasid A: Expression of transforming growth factor alpha in normal human adult kidney and enhanced expression of transforming growth factors alpha and beta 1 in renal cell carcinoma. Cancer Res 49: 6972-6975, 1989.
7. Ito N, Kawata S, Tamura S, Takaishi K, Shirai Y, Kiso S, Yabuuchi I, Matsuda Y, Nishioka M and Tarui S: Elevated levels of transforming growth factor beta messenger RNA and its polypeptide in human hepatocellular carcinoma. Cancer Res 51: 4080-4083, 1991.
8. Yoshida K, Yokozaki H, Niimoto M, Ito H, Ito M and Tahara E: Expression of TGF-beta and procollagen type I and type III in human gastric carcinomas. Int J Cancer 44: 394-398, 1989.
9. de Caestecker MP, Piek E and Roberts AB: Role of transforming growth factor-beta signaling in cancer. J Natl Cancer Inst 92: 1388-1402, 2000.
10. Takenoshita S, Hagiwara K, Nagashima M, Gemma A, Bennett WP and Harris CC: The genomic structure of the gene encoding the human transforming growth factor beta type II receptor (TGF-beta RII). Genomics 36: 341-344, 1996.
11. Konishi M, Kikuchi-Yanoshita R, Tanaka K, Muraoka M, Onda A, Okumuta Y, Kishi N, Iwama T, Mori T, Koike M, Ushio K, Chiba M, Nomizu S, Konishi F, Utsunomiya J and Miyaki M: Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer. Gastroenterology 111: 307-317, 1996.
12. Sobin LH and Wittekind C: TNM Classification of Malignant Tumours, 5th edition. New York: Wiley-Liss, Inc., 1997.
13. Stein A and Raoult D: A simple method for amplification of DNA from paraffin-embedded tissues. Nucleic Acids Res 20: 5237-5238, 1992.
14. Bae HW, Geiser AG, Kim DH, Chung MT, Burmester JK, Sporn MB, Roberts AB and Kim SJ: Characterization of the promoter region of the human transforming growth factor-beta type II receptor gene. J Biol Chem 270: 29460-29468, 1995.
15. Clark SJ, Harrison J, Paul CL and Frommer M: High sensitivity mapping of methylated cytosines. Nucleic Acids Res 22: 2990-2997, 1994.
16. Sowa Y, Orita T, Minamikawa-Hiranabe S, Mizuno T, Nomura H and Sakai T: Sp3, but not Spl, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor. Cancer Res 59: 4266-4270, 1999.
17. Avery A, Paraskeva C, Hall P, Flanders KC, Sporn M and Moorghen M: TGF-beta expression in the human colon: differential immunostaining along crypt epithelium. Br J Cancer 68: 137-139, 1993.
18. Eskinazi R, Resibois A, Svoboda M, Peny MO, Adler M, Robberecht P and Van Laethem JL: Expression of transforming growth factor beta receptors in normal human colon and sporadic adenocarcinomas. Gastroenterology 114: 1211-1220, 1998.
19. Arrick BA, Lopez AR, Elfman F, Ebner R, Damsky CH and Derynck R: Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor beta 1. J Cell Biol 118: 715-726, 1992.
20. Festuccia C, Angelucci A, Gravina GL, Villanova I, Teti A, Albini A and Bologna M: Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells. Int J Cancer 85: 407-415, 2000.
21. Garrigue-Antar L, Munoz-Antonia T, Antonia SJ, Gesmonde J, Vellucci VF and Reiss M: Missense mutations of the transforming growth factor beta type II receptor in human head and neck squamous carcinoma cells. Cancer Res 55: 3982-3987, 1995.
22. Wieser R, Attisano L, Wrana JL and Massague J: Signaling activity of transforming growth factor beta type II receptors lacking specific domains in the cytoplasmic region. Mol Cell Biol 13: 7239-7247, 1993.
23. Carcamo J, Zentella A and Massague J: Disruption of transforming growth factor beta signaling by a mutation that prevents transphosphorylation within the receptor complex. Mol Cell Biol 15: 1573-1581, 1995.
24. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW and Vogelstein B: Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268: 1336-1338, 1995.
25. Parsons R, Myeroff LL, Liu B, Willson JK, Markowitz SD, Kinzler KW and Vogelstein B: Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res 55: 5548-5550, 1995.
26. Takenoshita S, Tani M, Nagashima M, Hagiwara K, Bennett WP, Yokota J and Harris CC: Mutation analysis of coding sequences of the entire transforming growth factor beta type II receptor gene in sporadic human colon cancer using genomic DNA and intron primers. Oncogene 14: 1255-1258, 1997.
27. Jones PA and Laird PW: Cancer epigenetics comes of age. Nat Genet 21: 163-167, 1999.
28. Garrigue-Antar L, Souza RF, Vellucci VF, Meltzer SJ and Reiss M: Loss of transforming growth factor-beta type II receptor gene expression in primary human esophageal cancer. Lab Invest 75: 263-272, 1996.
29. de Jonge RR, Garrigue-Antar L, Vellucci VF and Reiss M: Frequent inactivation of the transforming growth factor beta type II receptor in small-cell lung carcinoma cells. Oncol Res 9: 89-98, 1997.
30. Hougaard S, Norgaard P, Abrahamsen N, Moses HL, Spang-Thomsen M and Skovgaard Poulsen H: Inactivation of the transforming growth factor beta type II receptor in human small cell lung cancer cell lines. Br J Cancer 79: 1005-1011, 1999. 3555-3559